JP2007537847A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007537847A5 JP2007537847A5 JP2007511507A JP2007511507A JP2007537847A5 JP 2007537847 A5 JP2007537847 A5 JP 2007537847A5 JP 2007511507 A JP2007511507 A JP 2007511507A JP 2007511507 A JP2007511507 A JP 2007511507A JP 2007537847 A5 JP2007537847 A5 JP 2007537847A5
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- channel
- thermal
- reagent
- microfluidic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000006243 chemical reaction Methods 0.000 claims description 391
- 239000003153 chemical reaction reagent Substances 0.000 claims description 160
- 239000000463 material Substances 0.000 claims description 86
- 239000000758 substrate Substances 0.000 claims description 81
- 238000004891 communication Methods 0.000 claims description 40
- 239000012528 membrane Substances 0.000 claims description 29
- 229910052710 silicon Inorganic materials 0.000 claims description 16
- 239000010703 silicon Substances 0.000 claims description 16
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 9
- 230000001276 controlling effect Effects 0.000 claims description 6
- 239000004065 semiconductor Substances 0.000 claims description 6
- 238000004805 robotic Methods 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 163
- 239000010410 layer Substances 0.000 description 148
- 239000012530 fluid Substances 0.000 description 134
- 230000003321 amplification Effects 0.000 description 81
- 238000003199 nucleic acid amplification method Methods 0.000 description 80
- 150000007523 nucleic acids Chemical class 0.000 description 78
- 239000000969 carrier Substances 0.000 description 75
- 108020004707 nucleic acids Proteins 0.000 description 75
- 229920001971 elastomer Polymers 0.000 description 71
- 238000003752 polymerase chain reaction Methods 0.000 description 71
- 239000000806 elastomer Substances 0.000 description 70
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 64
- 238000001514 detection method Methods 0.000 description 54
- 239000002773 nucleotide Substances 0.000 description 54
- 125000003729 nucleotide group Chemical group 0.000 description 54
- 239000000243 solution Substances 0.000 description 50
- 210000004027 cells Anatomy 0.000 description 46
- 238000000034 method Methods 0.000 description 45
- 238000004458 analytical method Methods 0.000 description 41
- 239000000047 product Substances 0.000 description 36
- 238000005382 thermal cycling Methods 0.000 description 35
- 239000000203 mixture Substances 0.000 description 34
- 239000000975 dye Substances 0.000 description 33
- 230000001681 protective Effects 0.000 description 31
- 230000000295 complement Effects 0.000 description 27
- 230000004224 protection Effects 0.000 description 25
- 102000004169 proteins and genes Human genes 0.000 description 24
- 108090000623 proteins and genes Proteins 0.000 description 24
- 239000011159 matrix material Substances 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 101700033661 ACTB Proteins 0.000 description 21
- 102100011550 ACTB Human genes 0.000 description 21
- 101710032514 ACTI Proteins 0.000 description 21
- 229920002120 photoresistant polymer Polymers 0.000 description 21
- 238000001704 evaporation Methods 0.000 description 20
- 229920000642 polymer Polymers 0.000 description 20
- 108020004999 Messenger RNA Proteins 0.000 description 17
- 230000027455 binding Effects 0.000 description 17
- 229920002106 messenger RNA Polymers 0.000 description 17
- 230000014509 gene expression Effects 0.000 description 16
- 229920000160 (ribonucleotides)n+m Polymers 0.000 description 15
- 102000004190 Enzymes Human genes 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 15
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 15
- 229920000272 Oligonucleotide Polymers 0.000 description 14
- 239000007789 gas Substances 0.000 description 14
- 238000010438 heat treatment Methods 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 238000007789 sealing Methods 0.000 description 13
- 108010001237 Cytochrome P-450 CYP2D6 Proteins 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 239000011521 glass Substances 0.000 description 12
- 230000003287 optical Effects 0.000 description 12
- 230000004044 response Effects 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 102100005543 CYP2D6 Human genes 0.000 description 11
- 238000001080 multi-layer soft lithography Methods 0.000 description 11
- 229920002676 Complementary DNA Polymers 0.000 description 10
- 239000000654 additive Substances 0.000 description 10
- 239000002299 complementary DNA Substances 0.000 description 10
- 238000010195 expression analysis Methods 0.000 description 10
- 241000239226 Scorpiones Species 0.000 description 9
- 238000004166 bioassay Methods 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 230000001809 detectable Effects 0.000 description 9
- 230000001965 increased Effects 0.000 description 9
- 102000004167 Ribonuclease P Human genes 0.000 description 8
- 108090000621 Ribonuclease P Proteins 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 230000000875 corresponding Effects 0.000 description 8
- 239000004205 dimethyl polysiloxane Substances 0.000 description 8
- 238000009826 distribution Methods 0.000 description 8
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 8
- 238000005755 formation reaction Methods 0.000 description 8
- 230000036571 hydration Effects 0.000 description 8
- 238000006703 hydration reaction Methods 0.000 description 8
- 239000003446 ligand Substances 0.000 description 8
- -1 nucleotide triphosphates Chemical class 0.000 description 8
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 8
- 230000002829 reduced Effects 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 7
- 229920000023 polynucleotide Polymers 0.000 description 7
- 238000003753 real-time PCR Methods 0.000 description 7
- 238000006722 reduction reaction Methods 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 229920001850 Nucleic acid sequence Polymers 0.000 description 6
- CXQXSVUQTKDNFP-UHFFFAOYSA-N Simethicone Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive Effects 0.000 description 6
- 230000000903 blocking Effects 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 6
- 238000005553 drilling Methods 0.000 description 6
- 238000011049 filling Methods 0.000 description 6
- 230000000887 hydrating Effects 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 239000002157 polynucleotide Substances 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000000376 reactant Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 235000012431 wafers Nutrition 0.000 description 6
- CZPWVGJYEJSRLH-UHFFFAOYSA-N 289-95-2 Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 5
- 102000033147 ERVK-25 Human genes 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 238000011068 load Methods 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 210000001519 tissues Anatomy 0.000 description 5
- 239000012472 biological sample Substances 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 238000007847 digital PCR Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 230000002708 enhancing Effects 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 238000007086 side reaction Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 230000002194 synthesizing Effects 0.000 description 4
- 238000004450 types of analysis Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 108091003117 Bovine Serum Albumin Proteins 0.000 description 3
- 229940098773 Bovine Serum Albumin Drugs 0.000 description 3
- 108010091873 DyNAzyme polymerase Proteins 0.000 description 3
- 108010092799 EC 2.7.7.49 Proteins 0.000 description 3
- 101700080605 NUC1 Proteins 0.000 description 3
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 3
- 239000002390 adhesive tape Substances 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000001351 cycling Effects 0.000 description 3
- 230000001419 dependent Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 238000004020 luminiscence type Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000006011 modification reaction Methods 0.000 description 3
- 239000002365 multiple layer Substances 0.000 description 3
- 101700006494 nucA Proteins 0.000 description 3
- 239000002853 nucleic acid probe Substances 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- 229910021420 polycrystalline silicon Inorganic materials 0.000 description 3
- 229920005591 polysilicon Polymers 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 230000001105 regulatory Effects 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 238000004528 spin coating Methods 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 102100001249 ALB Human genes 0.000 description 2
- 101710027066 ALB Proteins 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N DATI Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
- 101700011961 DPOM Proteins 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-N Deoxycytidine triphosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-N 0.000 description 2
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N Ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 101710029649 MDV043 Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 101700056996 PMDS Proteins 0.000 description 2
- 101700061424 POLB Proteins 0.000 description 2
- 210000002381 Plasma Anatomy 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 101700054624 RF1 Proteins 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- WYTGDNHDOZPMIW-UHOFOFEASA-O Serpentine Natural products O=C(OC)C=1[C@@H]2[C@@H]([C@@H](C)OC=1)C[n+]1c(c3[nH]c4c(c3cc1)cccc4)C2 WYTGDNHDOZPMIW-UHOFOFEASA-O 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M Tetra-n-butylammonium fluoride Chemical group [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Trimethylglycine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- FPKOPBFLPLFWAD-UHFFFAOYSA-N Trinitrotoluene Chemical compound CC1=CC=C([N+]([O-])=O)C([N+]([O-])=O)=C1[N+]([O-])=O FPKOPBFLPLFWAD-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 238000000225 bioluminescence resonance energy transfer Methods 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 230000036755 cellular response Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-J dATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-J 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drugs Drugs 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002060 fluorescence correlation spectroscopy Methods 0.000 description 2
- 238000003260 fluorescence intensity Methods 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000000608 laser ablation Methods 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 239000006249 magnetic particle Substances 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 230000036961 partial Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 238000000206 photolithography Methods 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 230000036678 protein binding Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N Acridine orange Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108020004425 Alu Elements Proteins 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000212384 Bifora Species 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 210000000601 Blood Cells Anatomy 0.000 description 1
- 150000000700 C-glycosides Chemical class 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N Deoxyguanosine triphosphate Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N Deoxyribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- 108020004461 Double-Stranded RNA Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 101710003775 ERVK-10 Proteins 0.000 description 1
- 101710037030 ERVK-11 Proteins 0.000 description 1
- 101710009283 ERVK-18 Proteins 0.000 description 1
- 101710009286 ERVK-19 Proteins 0.000 description 1
- 101710035700 ERVK-25 Proteins 0.000 description 1
- 101710038044 ERVK-6 Proteins 0.000 description 1
- 101710014468 ERVK-7 Proteins 0.000 description 1
- 101710014482 ERVK-8 Proteins 0.000 description 1
- 102100001542 EXO1 Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000004282 Grewia occidentalis Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 101710043924 HERVK_113 Proteins 0.000 description 1
- 102100005410 LINE-1 retrotransposable element ORF2 protein Human genes 0.000 description 1
- 210000000265 Leukocytes Anatomy 0.000 description 1
- CEQFOVLGLXCDCX-WUKNDPDISA-N Methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 description 1
- 229920002393 Microsatellite Polymers 0.000 description 1
- 229920002220 Minisatellite Polymers 0.000 description 1
- 108091007229 NSP3 Papain-like protease domain Proteins 0.000 description 1
- 108091005503 Nucleic proteins Proteins 0.000 description 1
- 210000004940 Nucleus Anatomy 0.000 description 1
- 108091005771 Peptidases Proteins 0.000 description 1
- 108010010677 Phosphodiesterase I Proteins 0.000 description 1
- 210000004910 Pleural fluid Anatomy 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene (PE) Substances 0.000 description 1
- 241001272996 Polyphylla fullo Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M Propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010078762 Protein Precursors Proteins 0.000 description 1
- 102000014961 Protein Precursors Human genes 0.000 description 1
- 101710006375 RNASEH1 Proteins 0.000 description 1
- 101700078434 RT67 Proteins 0.000 description 1
- 229920001914 Ribonucleotide Polymers 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 229910002808 Si–O–Si Inorganic materials 0.000 description 1
- 210000003802 Sputum Anatomy 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- OKIZCWYLBDKLSU-UHFFFAOYSA-M Tetramethylammonium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 1
- 241000205188 Thermococcus Species 0.000 description 1
- 241000589596 Thermus Species 0.000 description 1
- 241000589500 Thermus aquaticus Species 0.000 description 1
- MZZINWWGSYUHGU-UHFFFAOYSA-J ToTo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3S2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2S1 MZZINWWGSYUHGU-UHFFFAOYSA-J 0.000 description 1
- 231100000765 Toxin Toxicity 0.000 description 1
- 229920002605 Triple-stranded DNA Polymers 0.000 description 1
- 210000002700 Urine Anatomy 0.000 description 1
- UKRDPEFKFJNXQM-UHFFFAOYSA-N Vinylsilane Chemical compound [SiH3]C=C UKRDPEFKFJNXQM-UHFFFAOYSA-N 0.000 description 1
- GRRMZXFOOGQMFA-UHFFFAOYSA-J YOYO-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2O1 GRRMZXFOOGQMFA-UHFFFAOYSA-J 0.000 description 1
- ZYVSOIYQKUDENJ-MNGCYDFMSA-N [6-[[(6S,7S)-6-[4-[4-(5-acetyloxy-4-hydroxy-4,6-dimethyloxan-2-yl)oxy-5-hydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-7-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-4,10-dihydroxy-3-methyl-5-oxo-7,8-dihydro-6H-anthracen-2-yl]oxy]-4-(4- Chemical compound C([C@H]([C@@H](C(=O)C1=C(O)C2=C(O)C=3C)OC4OC(C)C(O)C(OC5OC(C)C(O)C(OC6OC(C)C(OC(C)=O)C(C)(O)C6)C5)C4)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)C1=CC2=CC=3OC(OC(C)C1OC(C)=O)CC1OC1CC(O)C(OC)C(C)O1 ZYVSOIYQKUDENJ-MNGCYDFMSA-N 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000003042 antagnostic Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000000840 anti-viral Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 241000617156 archaeon Species 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 108010003152 bacteriophage T7 RNA polymerase Proteins 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000001588 bifunctional Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 238000003965 capillary gas chromatography Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000001413 cellular Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000007374 clinical diagnostic method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000002508 contact lithography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000005712 crystallization Effects 0.000 description 1
- 238000010192 crystallographic characterization Methods 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 239000002019 doping agent Substances 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 230000001747 exhibiting Effects 0.000 description 1
- 108010007577 exodeoxyribonuclease I Proteins 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000002875 fluorescence polarization Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 238000007478 fluorogenic assay Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000002068 genetic Effects 0.000 description 1
- 201000002406 genetic disease Diseases 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 238000010841 mRNA extraction Methods 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000000051 modifying Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229940005943 ophthalmologic Antivirals Drugs 0.000 description 1
- 230000003204 osmotic Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000003071 parasitic Effects 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 244000052769 pathogens Species 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 230000002572 peristaltic Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000003449 preventive Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 229910052904 quartz Inorganic materials 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching Effects 0.000 description 1
- 108091007521 restriction endonucleases Proteins 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 101700086982 rnh Proteins 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000002821 scintillation proximity assay Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002210 silicon-based material Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000000087 stabilizing Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000004936 stimulating Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000007725 thermal activation Methods 0.000 description 1
- 239000002470 thermal conductor Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229940026754 topical Antivirals Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108020003112 toxins Proteins 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/837,885 | 2004-05-02 | ||
| US10/837,885 US7476363B2 (en) | 2003-04-03 | 2004-05-02 | Microfluidic devices and methods of using same |
| US10/876,046 US20050145496A1 (en) | 2003-04-03 | 2004-06-23 | Thermal reaction device and method for using the same |
| US10/876,046 | 2004-06-23 | ||
| US11/043,895 US8105553B2 (en) | 2004-01-25 | 2005-01-25 | Crystal forming devices and systems and methods for using the same |
| US11/043,895 | 2005-01-25 | ||
| US11/058,106 | 2005-02-14 | ||
| US11/058,106 US7867763B2 (en) | 2004-01-25 | 2005-02-14 | Integrated chip carriers with thermocycler interfaces and methods of using the same |
| PCT/US2005/015352 WO2005107938A2 (en) | 2004-05-02 | 2005-05-02 | Thermal reaction device and method for using the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012020787A Division JP2012085659A (ja) | 2004-05-02 | 2012-02-02 | 熱反応デバイスおよびその熱反応デバイスの使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007537847A JP2007537847A (ja) | 2007-12-27 |
| JP2007537847A5 true JP2007537847A5 (zh) | 2012-03-22 |
| JP5502275B2 JP5502275B2 (ja) | 2014-05-28 |
Family
ID=35320754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007511507A Active JP5502275B2 (ja) | 2004-05-02 | 2005-05-02 | 熱反応デバイスおよびその熱反応デバイスの使用方法 |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1796824A4 (zh) |
| JP (1) | JP5502275B2 (zh) |
| WO (1) | WO2005107938A2 (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7123903B2 (ja) | 2016-09-29 | 2022-08-23 | ダイアルノックス ゲーエムベーハー | サンプル容器配列物 |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4911722B2 (ja) | 2004-06-07 | 2012-04-04 | フルイディグム コーポレイション | 微小流体素子のための光学レンズシステムおよび方法 |
| CA2607661C (en) | 2005-05-09 | 2017-08-08 | Idaho Technology, Inc. | A device and method for two-stage nucleic acid amplification |
| US7913928B2 (en) | 2005-11-04 | 2011-03-29 | Alliant Techsystems Inc. | Adaptive structures, systems incorporating same and related methods |
| JP2007189964A (ja) * | 2006-01-20 | 2007-08-02 | Toppan Printing Co Ltd | 検査基板 |
| US8828661B2 (en) | 2006-04-24 | 2014-09-09 | Fluidigm Corporation | Methods for detection and quantification of nucleic acid or protein targets in a sample |
| WO2007141700A2 (en) | 2006-06-08 | 2007-12-13 | Koninklijke Philips Electronics N. V. | Microelectronic sensor device for dna detection |
| AU2007310987B2 (en) * | 2006-10-18 | 2014-01-09 | President And Fellows Of Harvard College | Lateral flow and flow-through bioassay devices based on patterned porous media, methods of making same, and methods of using same |
| CN101578520B (zh) | 2006-10-18 | 2015-09-16 | 哈佛学院院长等 | 基于形成图案的多孔介质的横向流动和穿过生物测定装置、及其制备方法和使用方法 |
| ES2809168T3 (es) * | 2006-11-15 | 2021-03-03 | Biofire Diagnostics Llc | Análisis biológico autónomo de alta densidad |
| US9102911B2 (en) | 2009-05-15 | 2015-08-11 | Biofire Diagnostics, Llc | High density self-contained biological analysis |
| US8157434B2 (en) | 2007-01-19 | 2012-04-17 | Fluidigm Corporation | High efficiency and high precision microfluidic devices and methods |
| JP2009042103A (ja) * | 2007-08-09 | 2009-02-26 | Sony Corp | 基板、これを用いた反応処理装置並びに反応制御方法 |
| JP5404638B2 (ja) * | 2007-11-07 | 2014-02-05 | ザ ユニヴァーシティ オブ ブリティッシュ コロンビア | マイクロ流体デバイスおよびその使用方法 |
| WO2009100449A1 (en) | 2008-02-08 | 2009-08-13 | Fluidigm Corporation | Dynamic array assay methods |
| CN101978272B (zh) | 2008-03-27 | 2015-02-04 | 哈佛学院院长等 | 基于纸的细胞阵列 |
| KR101510785B1 (ko) | 2008-03-27 | 2015-04-10 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 저렴한 멀티 검사 진단 플랫폼으로서의 무명실 |
| AU2009228091B2 (en) | 2008-03-27 | 2015-05-21 | President And Fellows Of Harvard College | Three-dimensional microfluidic devices |
| CA2719800A1 (en) | 2008-03-27 | 2009-10-01 | President And Fellows Of Harvard College | Paper-based microfluidic systems |
| US8961902B2 (en) * | 2008-04-23 | 2015-02-24 | Bioscale, Inc. | Method and apparatus for analyte processing |
| EP2300207A4 (en) | 2008-06-26 | 2012-05-09 | Harvard College | ACTIBLE NANOSTRUCTURED MATERIALS, HIGH ASPECT RATIO AND VERSATILE, BY REPLICATION |
| EP2326732A4 (en) | 2008-08-26 | 2012-11-14 | Fluidigm Corp | TEST METHODS FOR INCREASED SURPLUS OF SAMPLES AND / OR TARGETS |
| SG10201404683TA (en) * | 2008-12-08 | 2014-10-30 | Fluidigm Corp | Programmable microfluidic digital array |
| WO2010088288A2 (en) | 2009-01-28 | 2010-08-05 | Fluidigm Corporation | Determination of copy number differences by amplification |
| ES2612507T3 (es) | 2009-03-06 | 2017-05-17 | President And Fellows Of Harvard College | Dispositivos microfluídicos y electroquímicos |
| DE102009015739A1 (de) * | 2009-03-31 | 2010-10-07 | Siemens Aktiengesellschaft | Vorrichtung und Verfahren zur Aufnahme eines Sensors |
| US8691509B2 (en) | 2009-04-02 | 2014-04-08 | Fluidigm Corporation | Multi-primer amplification method for barcoding of target nucleic acids |
| US8551787B2 (en) | 2009-07-23 | 2013-10-08 | Fluidigm Corporation | Microfluidic devices and methods for binary mixing |
| WO2013134741A2 (en) | 2012-03-08 | 2013-09-12 | Cyvek, Inc. | Methods and systems for manufacture of microarray assay systems, conducting microfluidic assays, and monitoring and scanning to obtain microfluidic assay results |
| US9700889B2 (en) | 2009-11-23 | 2017-07-11 | Cyvek, Inc. | Methods and systems for manufacture of microarray assay systems, conducting microfluidic assays, and monitoring and scanning to obtain microfluidic assay results |
| US9500645B2 (en) | 2009-11-23 | 2016-11-22 | Cyvek, Inc. | Micro-tube particles for microfluidic assays and methods of manufacture |
| US9759718B2 (en) | 2009-11-23 | 2017-09-12 | Cyvek, Inc. | PDMS membrane-confined nucleic acid and antibody/antigen-functionalized microlength tube capture elements, and systems employing them, and methods of their use |
| US10065403B2 (en) | 2009-11-23 | 2018-09-04 | Cyvek, Inc. | Microfluidic assay assemblies and methods of manufacture |
| US9651568B2 (en) | 2009-11-23 | 2017-05-16 | Cyvek, Inc. | Methods and systems for epi-fluorescent monitoring and scanning for microfluidic assays |
| US9855735B2 (en) | 2009-11-23 | 2018-01-02 | Cyvek, Inc. | Portable microfluidic assay devices and methods of manufacture and use |
| WO2011063408A1 (en) | 2009-11-23 | 2011-05-26 | Cyvek, Inc. | Method and apparatus for performing assays |
| US8821810B2 (en) | 2010-02-03 | 2014-09-02 | President And Fellows Of Harvard College | Devices and methods for multiplexed assays |
| CN106552682B (zh) | 2011-03-22 | 2020-06-19 | 西维克公司 | 微流体装置以及制造方法和用途 |
| GB201106548D0 (en) | 2011-04-18 | 2011-06-01 | Evitraproteoma Ab | A method for determining ligand binding to a target protein using a thermal shift assahy |
| US9523693B2 (en) | 2011-04-18 | 2016-12-20 | Biotarget Engagement Interest Group Ab | Methods for determining ligand binding to a target protein using a thermal shift assay |
| WO2012154876A1 (en) | 2011-05-09 | 2012-11-15 | Fluidigm Corporation | Probe based nucleic acid detection |
| SG10201605049QA (en) | 2011-05-20 | 2016-07-28 | Fluidigm Corp | Nucleic acid encoding reactions |
| CN102320558B (zh) * | 2011-09-13 | 2014-03-26 | 上海先进半导体制造股份有限公司 | 全硅基微流体器件的腔体的制造方法 |
| DE102012100824A1 (de) * | 2012-02-01 | 2013-09-05 | Albert-Ludwigs-Universität Freiburg | Gemultiplexte Digital PCR |
| EP2820394B1 (en) | 2012-02-29 | 2017-07-12 | Fluidigm Corporation | Methods, systems, and devices for multiple single-cell capturing and processing using microfluidics |
| JP2015519900A (ja) | 2012-05-21 | 2015-07-16 | フリューダイム・コーポレイション | 粒子集団の単粒子解析方法及び単粒子単離方法 |
| US20140200167A1 (en) | 2012-08-01 | 2014-07-17 | Nanomdx, Inc. | Functionally integrated device for multiplex genetic identification |
| SG11201500649UA (en) * | 2012-08-03 | 2015-03-30 | Sony Corp | Nucleic acid analysis apparatus, microchip for nucleic acid analysis, and method for mounting microchip in nucleic acid analysis apparatus |
| US10767219B2 (en) * | 2014-03-11 | 2020-09-08 | Illumina, Inc. | Disposable, integrated microfluidic cartridge and methods of making and using same |
| US9373561B1 (en) | 2014-12-18 | 2016-06-21 | International Business Machines Corporation | Integrated circuit barrierless microfluidic channel |
| KR102385794B1 (ko) * | 2015-04-07 | 2022-04-11 | 셀 아이디 피티이 엘티디 | Dc 히터 |
| US10228367B2 (en) | 2015-12-01 | 2019-03-12 | ProteinSimple | Segmented multi-use automated assay cartridge |
| US11117113B2 (en) | 2015-12-16 | 2021-09-14 | Fluidigm Corporation | High-level multiplex amplification |
| US11402313B2 (en) | 2016-01-21 | 2022-08-02 | Tokyo Electron Limited | Foreign substance detection device and foreign substance detection method |
| CN109983165A (zh) * | 2016-09-23 | 2019-07-05 | 阿谢尔德克斯有限公司 | 对生物样品实施方案的文库制备系统的操作 |
| US20210129145A1 (en) * | 2017-08-14 | 2021-05-06 | Kimantech, L.L.C. | Liquid distribution device |
| CN109406442B (zh) * | 2018-10-30 | 2021-01-05 | 桂林电子科技大学 | 一种快速测量蛋白质热变性温度的方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5241450A (en) * | 1992-03-13 | 1993-08-31 | The United States Of America As Represented By The United States Department Of Energy | Three dimensional, multi-chip module |
| US5587128A (en) * | 1992-05-01 | 1996-12-24 | The Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification devices |
| US7351376B1 (en) * | 2000-06-05 | 2008-04-01 | California Institute Of Technology | Integrated active flux microfluidic devices and methods |
| EP1307749A4 (en) * | 2000-06-15 | 2005-04-20 | Irm Llc | AUTOMATED PRECISION OBJEK HOLDER |
| US6627159B1 (en) * | 2000-06-28 | 2003-09-30 | 3M Innovative Properties Company | Centrifugal filling of sample processing devices |
| US6508988B1 (en) * | 2000-10-03 | 2003-01-21 | California Institute Of Technology | Combinatorial synthesis system |
| US6960437B2 (en) * | 2001-04-06 | 2005-11-01 | California Institute Of Technology | Nucleic acid amplification utilizing microfluidic devices |
| EP1975539A2 (en) * | 2001-10-29 | 2008-10-01 | CHART HEAT EXCHANGERS Limited Partnership | Heat exchangers |
| US20030175947A1 (en) * | 2001-11-05 | 2003-09-18 | Liu Robin Hui | Enhanced mixing in microfluidic devices |
| JP4355210B2 (ja) * | 2001-11-30 | 2009-10-28 | フルイディグム コーポレイション | 微小流体デバイスおよび微小流体デバイスの使用方法 |
| US6893613B2 (en) * | 2002-01-25 | 2005-05-17 | Bristol-Myers Squibb Company | Parallel chemistry reactor with interchangeable vessel carrying inserts |
| US7198759B2 (en) * | 2002-07-26 | 2007-04-03 | Applera Corporation | Microfluidic devices, methods, and systems |
| US7452712B2 (en) * | 2002-07-30 | 2008-11-18 | Applied Biosystems Inc. | Sample block apparatus and method of maintaining a microcard on a sample block |
| AU2003291439A1 (en) * | 2002-11-08 | 2004-06-03 | Irm, Llc | Apparatus and methods to process substrate surface features |
| WO2004089810A2 (en) * | 2003-04-03 | 2004-10-21 | Fluidigm Corp. | Microfluidic devices and methods of using same |
-
2005
- 2005-05-02 EP EP05766055.7A patent/EP1796824A4/en not_active Withdrawn
- 2005-05-02 JP JP2007511507A patent/JP5502275B2/ja active Active
- 2005-05-02 WO PCT/US2005/015352 patent/WO2005107938A2/en active Application Filing
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7123903B2 (ja) | 2016-09-29 | 2022-08-23 | ダイアルノックス ゲーエムベーハー | サンプル容器配列物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5502275B2 (ja) | 熱反応デバイスおよびその熱反応デバイスの使用方法 | |
| US10131934B2 (en) | Thermal reaction device and method for using the same | |
| JP2007537847A5 (zh) | ||
| US7867454B2 (en) | Thermal reaction device and method for using the same | |
| US8007746B2 (en) | Microfluidic devices and methods of using same | |
| US8828663B2 (en) | Thermal reaction device and method for using the same | |
| US7837946B2 (en) | Microfluidic device and methods of using same | |
| US7666361B2 (en) | Microfluidic devices and methods of using same | |
| JP4355210B2 (ja) | 微小流体デバイスおよび微小流体デバイスの使用方法 | |
| EP2518161A1 (en) | Method for detection of mutant alleles | |
| US20180243741A1 (en) | Thermal reaction device and method for using the same | |
| JP2012085659A (ja) | 熱反応デバイスおよびその熱反応デバイスの使用方法 | |
| CA2807591C (en) | Microfluidic devices and methods of using same |